The 2019 event will showcase invited presentations, abstracts, small group sessions and a lively scientific interchange on anal HPV infection, anal squamous intraepithelial lesions and anal cancer.
Educational Learning objectives
Determining populations at-risk for anal HSIL and cancer, and optimal strategies for screening.
Updates and new developments in molecular biology and pathogenesis of anal HPV, HSIL and cancer.
Strategies for and new developments in treatment of anal HSIL and cancer.
Improving the infra-structure and knowledge base for HRA providers. Understanding the limitations of different health care systems in providing HRA.
Understanding the optimal use of the HPV vaccine for prevention of anal canal disease; discussing the potential for off-label use in preventing development and recurrence of HPV-associated anal canal disease in at-risk populations.
IANS is now accepting abstract submissions for IANS Scientific Meeting 2019
Abstracts must be 250 words or less (not including the title). Follow all instructions for completing the submission. Be sure to structure the content into Background, Methods, Results and Conclusions sections. Please email submissions to [email protected]
Abstracts must be submitted by 11.59pm U.S. EDT on August 25 2019. Abstract authors will be notified of the status of their submission after their abstracts have been reviewed. Be sure to read and adhere to the Abstract Terms and Conditions.
Deadline: August 25, 2019 at 11:59am EDT